Cargando…

The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years

Myocardial infarction (MI) is the most frequent end-point of cardiovascular pathology, leading to higher mortality worldwide. Due to the particularity of the heart tissue, patients who experience ischemic infarction of the heart, still suffered irreversible damage to the heart even if the vascular r...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Chan, Liu, Binghong, Wang, Ruiying, Li, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801508/
https://www.ncbi.nlm.nih.gov/pubmed/35111829
http://dx.doi.org/10.3389/fcvm.2021.809580
_version_ 1784642476504514560
author Wu, Chan
Liu, Binghong
Wang, Ruiying
Li, Gang
author_facet Wu, Chan
Liu, Binghong
Wang, Ruiying
Li, Gang
author_sort Wu, Chan
collection PubMed
description Myocardial infarction (MI) is the most frequent end-point of cardiovascular pathology, leading to higher mortality worldwide. Due to the particularity of the heart tissue, patients who experience ischemic infarction of the heart, still suffered irreversible damage to the heart even if the vascular reflow by treatment, and severe ones can lead to heart failure or even death. In recent years, several studies have shown that microRNAs (miRNAs), playing a regulatory role in damaged hearts, bring light for patients to alleviate MI. In this review, we summarized the effect of miRNAs on MI with some mechanisms, such as apoptosis, autophagy, proliferation, inflammatory; the regulation of miRNAs on cardiac structural changes after MI, including angiogenesis, myocardial remodeling, fibrosis; the application of miRNAs in stem cell therapy and clinical diagnosis; other non-coding RNAs related to miRNAs in MI during the past 5 years.
format Online
Article
Text
id pubmed-8801508
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88015082022-02-01 The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years Wu, Chan Liu, Binghong Wang, Ruiying Li, Gang Front Cardiovasc Med Cardiovascular Medicine Myocardial infarction (MI) is the most frequent end-point of cardiovascular pathology, leading to higher mortality worldwide. Due to the particularity of the heart tissue, patients who experience ischemic infarction of the heart, still suffered irreversible damage to the heart even if the vascular reflow by treatment, and severe ones can lead to heart failure or even death. In recent years, several studies have shown that microRNAs (miRNAs), playing a regulatory role in damaged hearts, bring light for patients to alleviate MI. In this review, we summarized the effect of miRNAs on MI with some mechanisms, such as apoptosis, autophagy, proliferation, inflammatory; the regulation of miRNAs on cardiac structural changes after MI, including angiogenesis, myocardial remodeling, fibrosis; the application of miRNAs in stem cell therapy and clinical diagnosis; other non-coding RNAs related to miRNAs in MI during the past 5 years. Frontiers Media S.A. 2022-01-17 /pmc/articles/PMC8801508/ /pubmed/35111829 http://dx.doi.org/10.3389/fcvm.2021.809580 Text en Copyright © 2022 Wu, Liu, Wang and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Wu, Chan
Liu, Binghong
Wang, Ruiying
Li, Gang
The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years
title The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years
title_full The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years
title_fullStr The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years
title_full_unstemmed The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years
title_short The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years
title_sort regulation mechanisms and clinical application of micrornas in myocardial infarction: a review of the recent 5 years
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801508/
https://www.ncbi.nlm.nih.gov/pubmed/35111829
http://dx.doi.org/10.3389/fcvm.2021.809580
work_keys_str_mv AT wuchan theregulationmechanismsandclinicalapplicationofmicrornasinmyocardialinfarctionareviewoftherecent5years
AT liubinghong theregulationmechanismsandclinicalapplicationofmicrornasinmyocardialinfarctionareviewoftherecent5years
AT wangruiying theregulationmechanismsandclinicalapplicationofmicrornasinmyocardialinfarctionareviewoftherecent5years
AT ligang theregulationmechanismsandclinicalapplicationofmicrornasinmyocardialinfarctionareviewoftherecent5years
AT wuchan regulationmechanismsandclinicalapplicationofmicrornasinmyocardialinfarctionareviewoftherecent5years
AT liubinghong regulationmechanismsandclinicalapplicationofmicrornasinmyocardialinfarctionareviewoftherecent5years
AT wangruiying regulationmechanismsandclinicalapplicationofmicrornasinmyocardialinfarctionareviewoftherecent5years
AT ligang regulationmechanismsandclinicalapplicationofmicrornasinmyocardialinfarctionareviewoftherecent5years